Latest Institutional Purchases of Santen Pharmaceutical CO Unspo (SNPHY)
This list provides information on the latest institutional transactions involving Santen Pharmaceutical CO Unspo (SNPHY) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 24, 2025
Q4 2024
|
Copeland Capital Management, LLC
|
BUY
|
- |
230New |
$2.13K - $2.91K
|
230
$2.24K
|
|
| Q1 2024 | |||||||
|
May 10, 2024
Q1 2024
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
BUY
|
- |
26New |
$247 - $281
|
26
$254
|
|
| Q2 2023 | |||||||
|
Aug 08, 2023
Q2 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
30New |
$236 - $287
|
30
$293
|
|
| Q2 2022 | |||||||
|
Jul 28, 2022
Q2 2022
|
Private Capital Group, LLC
|
BUY
|
- |
40+ 111.11% |
$289 - $399
|
76
$741
|
|
| Q1 2022 | |||||||
|
May 10, 2022
Q1 2022
|
Meeder Asset Management Inc
|
BUY
|
- |
199New |
$1.99K - $2.48K
|
199
$1.94K
|
|